ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
MixedBag
|
46 |
13K |
10 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
13K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
MixedBag
|
412 |
113K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
412
|
113K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
MixedBag
|
412 |
113K |
11 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
412
|
113K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
MixedBag
|
54 |
16K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
54
|
16K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Final Director's Interest Notice
|
|
MixedBag
|
19 |
5.5K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
19
|
5.5K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Biotech Time?
|
|
MixedBag
|
14 |
3.0K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
14
|
3.0K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Biotech Time?
|
|
MixedBag
|
14 |
3.0K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
14
|
3.0K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Biotech Time?
|
|
MixedBag
|
14 |
3.0K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
14
|
3.0K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
MixedBag
|
37 |
12K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
37
|
12K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Biotech Time?
|
|
MixedBag
|
14 |
3.0K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
14
|
3.0K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Biotech Time?
|
|
MixedBag
|
14 |
3.0K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
14
|
3.0K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
MixedBag
|
91 |
25K |
9 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
25K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
MixedBag
|
327 |
100K |
10 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
327
|
100K
|
10
|
|
ASX - By Stock
|
ALU |
Re:
Ann: Altium enters into binding SIA with Renesas
|
|
MixedBag
|
59 |
37K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
59
|
37K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
MixedBag
|
59 |
20K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
59
|
20K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
MixedBag
|
59 |
20K |
0 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
59
|
20K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
MixedBag
|
327 |
100K |
7 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
327
|
100K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
MixedBag
|
327 |
100K |
15 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
327
|
100K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
MixedBag
|
59 |
20K |
1 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
59
|
20K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
MixedBag
|
59 |
20K |
4 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
59
|
20K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
MixedBag
|
59 |
20K |
6 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
59
|
20K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Receives $7.36m R&D Tax Incentive Refund
|
|
MixedBag
|
52 |
16K |
15 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
52
|
16K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
MixedBag
|
236 |
77K |
1 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
236
|
77K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
MixedBag
|
236 |
77K |
38 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
236
|
77K
|
38
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
MixedBag
|
236 |
77K |
13 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
236
|
77K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
MixedBag
|
974 |
314K |
8 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
974
|
314K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
MixedBag
|
974 |
314K |
3 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
974
|
314K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
MixedBag
|
974 |
314K |
1 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
974
|
314K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
MixedBag
|
974 |
314K |
14 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
974
|
314K
|
14
|
|
ASX - By Stock
|
PAR |
Re:
Just a holiday?
|
|
MixedBag
|
55 |
23K |
0 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
55
|
23K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
MixedBag
|
974 |
314K |
16 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
974
|
314K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
Ann: The Hon Kim Beazley AC Joins Orthocell Board
|
|
MixedBag
|
25 |
6.3K |
3 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
25
|
6.3K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Just a holiday?
|
|
MixedBag
|
55 |
23K |
1 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
55
|
23K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Just a holiday?
|
|
MixedBag
|
55 |
23K |
2 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
55
|
23K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
MixedBag
|
974 |
314K |
8 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
974
|
314K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
MixedBag
|
4.2K |
3.7M |
4 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
4.2K
|
3.7M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Listing of Options - Top 20 Holders and Distribution Reports
|
|
MixedBag
|
14 |
5.2K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
14
|
5.2K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
MixedBag
|
95 |
28K |
0 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
95
|
28K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
MixedBag
|
95 |
28K |
4 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
95
|
28K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
MixedBag
|
496 |
153K |
3 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
496
|
153K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
MixedBag
|
496 |
153K |
4 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
496
|
153K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
MixedBag
|
75 |
25K |
16 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
75
|
25K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Successful OrthoATI clinical trial
|
|
MixedBag
|
47 |
11K |
6 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
47
|
11K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
MixedBag
|
191 |
55K |
1 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
191
|
55K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR Capital Position and 2024 Raising Requirements
|
|
MixedBag
|
120 |
40K |
5 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
120
|
40K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
MixedBag
|
191 |
55K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
191
|
55K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
MixedBag
|
191 |
55K |
16 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
191
|
55K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
MixedBag
|
191 |
55K |
15 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
191
|
55K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Fin Rev- Paradigm looking to raise funds
|
|
MixedBag
|
101 |
29K |
8 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
101
|
29K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
MixedBag
|
218 |
73K |
12 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
73K
|
12
|
|